112 related articles for article (PubMed ID: 22344855)
1. Fasudil inhibits lung carcinoma-conditioned endothelial cell viability and migration.
Zhang Z; Ren JH; Li ZY; Nong L; Wu G
Oncol Rep; 2012 May; 27(5):1561-6. PubMed ID: 22344855
[TBL] [Abstract][Full Text] [Related]
2. Rho kinase inhibitor fasudil suppresses migration and invasion though down-regulating the expression of VEGF in lung cancer cell line A549.
Zhu F; Zhang Z; Wu G; Li Z; Zhang R; Ren J; Nong L
Med Oncol; 2011 Jun; 28(2):565-71. PubMed ID: 20300976
[TBL] [Abstract][Full Text] [Related]
3. Fasudil inhibits prostate cancer-induced angiogenesis in vitro.
Chen W; Mao K; Hua-Huy T; Bei Y; Liu Z; Dinh-Xuan AT
Oncol Rep; 2014 Dec; 32(6):2795-802. PubMed ID: 25333508
[TBL] [Abstract][Full Text] [Related]
4. RhoA/ROCK pathway inhibition by fasudil suppresses the vasculogenic mimicry of U2OS osteosarcoma cells in vitro.
Xia Y; Cai X; Fan J; Zhang L; Li Z; Ren J; Wu G; Zhu F
Anticancer Drugs; 2017 Jun; 28(5):514-521. PubMed ID: 28225457
[TBL] [Abstract][Full Text] [Related]
5. Fasudil inhibits vascular endothelial growth factor-induced angiogenesis in vitro and in vivo.
Yin L; Morishige K; Takahashi T; Hashimoto K; Ogata S; Tsutsumi S; Takata K; Ohta T; Kawagoe J; Takahashi K; Kurachi H
Mol Cancer Ther; 2007 May; 6(5):1517-25. PubMed ID: 17513600
[TBL] [Abstract][Full Text] [Related]
6. Rho kinase inhibition by fasudil suppresses lipopolysaccharide-induced apoptosis of rat pulmonary microvascular endothelial cells via JNK and p38 MAPK pathway.
Liu H; Chen X; Han Y; Li C; Chen P; Su S; Zhang Y; Pan Z
Biomed Pharmacother; 2014 Apr; 68(3):267-75. PubMed ID: 24406296
[TBL] [Abstract][Full Text] [Related]
7. ROCK inhibitor fasudil attenuated high glucose-induced MCP-1 and VCAM-1 expression and monocyte-endothelial cell adhesion.
Li H; Peng W; Jian W; Li Y; Li Q; Li W; Xu Y
Cardiovasc Diabetol; 2012 Jun; 11():65. PubMed ID: 22694757
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor.
Hata Y; Miura M; Nakao S; Kawahara S; Kita T; Ishibashi T
Jpn J Ophthalmol; 2008; 52(1):16-23. PubMed ID: 18369695
[TBL] [Abstract][Full Text] [Related]
9. ROCK inhibition with Fasudil induces beta-catenin nuclear translocation and inhibits cell migration of MDA-MB 231 human breast cancer cells.
Guerra FS; Oliveira RG; Fraga CAM; Mermelstein CDS; Fernandes PD
Sci Rep; 2017 Oct; 7(1):13723. PubMed ID: 29057980
[TBL] [Abstract][Full Text] [Related]
10. The Rho kinase inhibitor fasudil inhibits the migratory behaviour of 95-D lung carcinoma cells.
Yang X; Liu Y; Zong Z; Tian D
Biomed Pharmacother; 2010 Jan; 64(1):58-62. PubMed ID: 19879105
[TBL] [Abstract][Full Text] [Related]
11. [Effects of the Rho-kinase inhibitor fasudil on the invasion, migration, and apoptosis of human prostate cancer PC3 and DU145 cells].
Gao QQ; Chen H; Chen Y; Xu ZP; Zhu LL; Yu W; Han YF; Dai YT
Zhonghua Nan Ke Xue; 2016 Jun; 22(6):483-490. PubMed ID: 28963834
[TBL] [Abstract][Full Text] [Related]
12. Rho Kinase Inhibitor Fasudil Suppresses the Vasculogenic Mimicry of B16 Mouse Melanoma Cells Both In Vitro and In Vivo.
Xia Y; Cai XY; Fan JQ; Zhang LL; Ren JH; Chen J; Li ZY; Zhang RG; Zhu F; Wu G
Mol Cancer Ther; 2015 Jul; 14(7):1582-90. PubMed ID: 25934709
[TBL] [Abstract][Full Text] [Related]
13. The Rho kinase inhibitor fasudil augments the number of functional endothelial progenitor cells in ex vivo cultures.
O E; Ahn HY; Kim HK; You JC; Shin JC; Joe YA
Int J Mol Med; 2011 Sep; 28(3):357-63. PubMed ID: 21567077
[TBL] [Abstract][Full Text] [Related]
14. The Rho-kinase inhibitor inhibits proliferation and metastasis of small cell lung cancer.
Yang X; Di J; Zhang Y; Zhang S; Lu J; Liu J; Shi W
Biomed Pharmacother; 2012 Apr; 66(3):221-7. PubMed ID: 22425182
[TBL] [Abstract][Full Text] [Related]
15. Fasudil attenuates lipopolysaccharide-induced acute lung injury in mice through the Rho/Rho kinase pathway.
Li Y; Wu Y; Wang Z; Zhang XH; Wu WK
Med Sci Monit; 2010 Apr; 16(4):BR112-118. PubMed ID: 20357711
[TBL] [Abstract][Full Text] [Related]
16. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
[TBL] [Abstract][Full Text] [Related]
17. Fasudil inhibits neutrophil-endothelial cell interactions by regulating the expressions of GRP78 and BMPR2.
Wang J; Xu J; Zhao X; Xie W; Wang H; Kong H
Exp Cell Res; 2018 Apr; 365(1):97-105. PubMed ID: 29481792
[TBL] [Abstract][Full Text] [Related]
18. [Fasudil inhibits HSC adhesion, migration and proliferation via Rho/ROCK pathway].
Wang YZ; Jiang HQ; Hu CX; Chen X
Zhonghua Gan Zang Bing Za Zhi; 2006 Nov; 14(11):821-3. PubMed ID: 17125608
[TBL] [Abstract][Full Text] [Related]
19. Effect of fasudil on growth, adhesion, invasion, and migration of 95D lung carcinoma cells in vitro.
Yang X; Zhang Y; Wang S; Shi W
Can J Physiol Pharmacol; 2010 Sep; 88(9):874-9. PubMed ID: 20921973
[TBL] [Abstract][Full Text] [Related]
20. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
Chen XY; Dun JN; Miao QF; Zhang YJ
Pharmacology; 2009; 83(2):67-79. PubMed ID: 19052484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
